Companies · Other Health Care

J&J Solutions Inc

NEEDHAM · Other Health Care

Diligence memoA one-page analyst read on J&J Solutions Inc — recommendation, valuation, rhythm, risks.
$29.0M
Total raised · real
6
Rounds
0.1×
Latest step-up
Top 13%
Sector rank · raised
Series A
Latest stage · inferred · Tue Feb 04 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

J&J Solutions Inc looks under-valued against its niche peers and is dormant on financing cadence.

Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the health care sector profile.

Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.

Under-valued
  • Modeled value is 0.05× the median modeled value of Series A Other Health Care companies in 2019–2021 (164 peers) — value vs value, same stage and era.
  • Issuer reports $0–$1M revenue while modeled below niche peers.
Dormant
  • Last raise 6.4 yr ago; this sector typically re-raises about every 14 months.
  • Silent for over 3× the sector's normal cadence.
Leadership

No named principal in this company's public records yet — see all operators below.

Explore how these operators interlock with other companies in the operator network.

Where it sits in Other Health Care

J&J Solutions Inc is one of 5377 Other Health Care companies tracked from NEEDHAM. By capital raised it ranks in the upper tier (ahead of 88% of sector peers), and in the long tail by modeled valuation est..

Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.

As reported in public records reported — not modeled.

US
Jurisdiction
$0–$1M
Issuer revenue
Rule 506(b)
Reg D exemption
1
Investors (latest)
2020-02-04
First sale
Amount raised vs valuation, by round

Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.

Amount raised · realModeled valuation · estCumulative funded · real
$0$125M$250M$375M$500MPre-Seed · 2010-01-04 Raised $600K (real) Modeled valuation $18M (est)Pre-Seed2010Seed · 2012-07-19 Raised $2.3M (real) Modeled valuation $56M (est)Seed2012Seed · 2012-07-19 Raised $3.5M (real) Modeled valuation $87M (est)Seed2012Seed · 2012-07-19 Raised $3.3M (real) Modeled valuation $81M (est)Seed2012Series A · 2012-07-19 Raised $9.6M (real) Modeled valuation $193M (est)Series A2012Series A · 2016-02-12 Raised $3.8M (real) Modeled valuation $77M (est)Series A2016Series A · 2018-01-31 Raised $12M (real) Modeled valuation $234M (est)Series A2018Series A · 2018-01-31 Raised $13M (real) Modeled valuation $261M (est)Series A2018Series A · 2019-08-30 Raised $1.8M (real) Modeled valuation $37M (est)Series A2019Series A · 2020-02-04 Raised $250K (real) Modeled valuation $5.0M (est)Series A2020+$2.3M+$3.5M+$3.3M+$9.6M+$3.8M+$12M+$13M+$1.8M+$250KCumulative $50M

The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.

Financing ladder & sequence gaps
Pre-Seed$600K · 2010
Seed$2.3M · 2012
Seed extension$3.5M · 2012
Seed extension$3.3M · 2012
Series A$9.6M · 2012
Series A extension$3.8M · 2016
Series A extension$11.6M · 2018
Series A extension$12.9M · 2018
Series A extension$1.8M · 2019
Series A extension$250K · 2020

Stages are modeled from round size (public records carry no series label). Ladder is contiguous — every modeled rung has a record.

Modeled valuation trajectory
$5.0M
Base estimate est.
$320K
Conservative case
$27.4M
Upside case
$1.1M
Modeled post-money

Round size and date are reported; the stage label is inferred from round size (latest is Series Aa $4.0M–$15M round). Valuation is modeled from stage benchmarks scaled by the health care sector profile. Directional, not a quoted figure.

Pre-Seed · modeled $18.5M · 2010-01-042010Seed · modeled $56.4M · 2012-07-19Seed · modeled $87.3M · 2012-07-19Seed · modeled $80.7M · 2012-07-19Series A · modeled $193.3M · 2012-07-19Series A · modeled $77.2M · 2016-02-12Series A · modeled $233.5M · 2018-01-31Series A · modeled $260.7M · 2018-01-31Series A · modeled $36.9M · 2019-08-30Series A · modeled $5.0M · 2020-02-042020
Model inputs · modeled:benchmark-stage-stepup-v1
22%
Dilution assumption
Implied ownership sold in the financing.
52%
Survival probability
28% low · 71% high
1.43×/yr
Annual markup
1.80×/yr upside case
6.0 yr
Elapsed time used
6.4 yr actual, capped for stale marks
health care
Sector profile
Adjusts growth and survival by industry.
Financing rhythm
13 mo
Avg between rounds
$2.9M/yr
Capital velocity
16.5 yr
On record since
2010
First round
10
Rounds on file
How it compares to the market

Benchmarked against 5377 companies in Other Health Care. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.

Total raised — vs sector median (real $, all stages) 12× above median
This company$29.0M
Sector median$2.4M
Latest round — vs other Series A rounds in sector (real $, this stage) 0.0× of median
This company$250K
Sector median$5.6M
Modeled value — vs sector median (estimate, all stages) 0.2× of median
This company$5.0M
Sector median$22.1M

Raised more than 88% of sector peers (real $). Modeled value above 21% of peers (estimate).

Niche peers — same stage & era

A tighter cohort than the sector chart above — only companies at the same stage (Series A) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful. This company ranks #160 of 164.

This companyCohort peer
$1.0M$10.0M$100.0M$1.0B$10.0M$100.0MCapital raised (log)InvestCo Tabletop, LLC · Series A Raised $15.0M · modeled $302.7M (est)Mediphore, Inc. · Series A Raised $15.0M · modeled $302.7M (est)iVinci Partners, LLC · Series A Raised $34.8M · modeled $302.7M (est)Oklahoma Proton Center LLC · Series A Raised $14.0M · modeled $282.5M (est)MicroOptx, Inc. · Series A Raised $17.8M · modeled $278.6M (est)ProxsysRx, Inc. · Series A Raised $14.6M · modeled $260.0M (est)Biolux Research Holdings, Inc. · Series A Raised $12.7M · modeled $256.3M (est)Fountain Life Holdings, LLC · Series A Raised $17.1M · modeled $238.6M (est)Equality Management Holdings, LLC · Series A Raised $14.4M · modeled $232.3M (est)Olympus Ascent Investors, LLC · Series A Raised $11.5M · modeled $232.0M (est)EDS Holdco LLC · Series A Raised $12.3M · modeled $221.5M (est)Zipari, Inc. · Series A Raised $29.6M · modeled $208.3M (est)J&J Solutions Inc (this company) Raised $29.0M · modeled $5.0M (est)J&J Solutions Inc
CompanyStageRaised · realValue · estvs peer med.
InvestCo Tabletop, LLCSeries A$15.0M$302.7M3.00×
Mediphore, Inc.Series A$15.0M$302.7M3.00×
iVinci Partners, LLCSeries A$34.8M$302.7M3.00×
Oklahoma Proton Center LLCSeries A$14.0M$282.5M2.80×
MicroOptx, Inc.Series A$17.8M$278.6M2.76×
ProxsysRx, Inc.Series A$14.6M$260.0M2.58×
Biolux Research Holdings, Inc.Series A$12.7M$256.3M2.54×
Fountain Life Holdings, LLCSeries A$17.1M$238.6M2.36×
Equality Management Holdings, LLCSeries A$14.4M$232.3M2.30×
Olympus Ascent Investors, LLCSeries A$11.5M$232.0M2.30×
EDS Holdco LLCSeries A$12.3M$221.5M2.20×
Zipari, Inc.Series A$29.6M$208.3M2.06×
J&J Solutions Inc this companySeries A$29.0M$5.0M0.05×
Full financing history

Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.

StageAmount · realAnnouncedPost-money · estValue · estConf.
Pre-Seed$600K2010-01-04$3.3M$18.5M85%
Seed$2.3M2012-07-19$11.4M$56.4M85%
Seed$3.5M2012-07-19$17.6M$87.3M85%
Seed$3.3M2012-07-19$16.3M$80.7M85%
Series A$9.6M2012-07-19$43.5M$193.3M85%
Series A$3.8M2016-02-12$17.4M$77.2M85%
Series A$11.6M2018-01-31$52.6M$233.5M90%
Series A$12.9M2018-01-31$58.7M$260.7M90%
Series A$1.8M2019-08-30$8.3M$36.9M90%
Series A$250K2020-02-04$1.1M$5.0M90%
What happened at each round

Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.

  1. Pre-Seed$600K2010-01-04
    • First recorded raise — entered as Pre-Seed.
    • 7 investors on this round.
  2. Seed$2.3M2012-07-19
    • Raised again after 30 mo — slower than the ~14 mo sector norm.
    • Round 3.8× larger than the prior — scaling up.
    • 25 investors on this round.
  3. Seed$3.5M2012-07-19
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round 1.5× larger than the prior — scaling up.
    • Switched to Rule 506(b) (was Rule 06).
    • 64 investors on this round.
  4. Seed$3.3M2012-07-19
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round roughly the size of the prior one.
    • Switched to Rule 06 (was Rule 506(b)).
    • 55 investors on this round.
  5. Series A$9.6M2012-07-19
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round 2.9× larger than the prior — scaling up.
    • Switched to Rule 506(b) (was Rule 06).
    • 113 investors on this round.
  6. Series A$3.8M2016-02-12
    • Raised again after 43 mo — slower than the ~14 mo sector norm.
    • Round 2.5× smaller than the prior — bridge or down round.
    • 2 investors on this round.
  7. Series A$11.6M2018-01-31
    • Raised again after 24 mo — slower than the ~14 mo sector norm.
    • Round 3.0× larger than the prior — scaling up.
    • Revenue band moved No revenue → $0–$1M.
    • 46 investors on this round.
  8. Series A$12.9M2018-01-31
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round roughly the size of the prior one.
    • 76 investors on this round.
  9. Series A$1.8M2019-08-30
    • Raised 19 mo later, in step with the ~14 mo sector norm.
    • Round 7.1× smaller than the prior — bridge or down round.
    • 68 investors on this round.
  10. Series A$250K2020-02-04
    • Came back fast: 5 mo vs the ~14 mo sector norm.
    • Round 7.3× smaller than the prior — bridge or down round.
    • 1 investor on this round.
Intelligence
2021 ~Q1
Modeled next raise · ~13mo cadence
$250K
Modeled next size est.range $250K$400K
0.1×
Last step-up
$2.9M/yr
Capital velocity

Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.

Key people & operators

Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.

PersonRoleAlso runsTied since
Jeffrey L. Hanthorn1 other2018-01
JOHN R. SLUMP1 other2010-01
Kent T. Smith1 other2012-07
Mark J Drish1 other2016-02
Steven K. Braun1 other2018-01
Curtis R Nelson2012-07
Douglas D Rohall2018-01
JARED M. GARFIELD2010-01
Matthew T Busick2012-07
Mitch S Moeller2019-08
Mitch T Moeller2018-01
PAUL D SYLVAN2019-08
Paul E Sylvan2018-01
PAUL S SMITH2019-08
Paul T Smith2018-01
Prasad T Sunkara2012-07
Richard B Steele2018-01
RICHARD S STEELE2019-08
Terry T Sullivan2012-07
Timothy G Tyler2018-01
Timothy T Tyler2016-02
Registry & provenance

J&J Solutions Inc is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.

United States
Country of record
US
Jurisdiction
1451840
SEC CIK
Similar companies

Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.

CompanySectorStageRaised · realValue · estWhy similar
Headlands Research, Inc.Other Health CareSeries A$29.2M$4.5Msame sector · same stage
McGinley Orthopaedic Innovations, LLCOther Health CareSeries A$25.3M$4.6Msame sector · same stage
Heart Test Laboratories, Inc.Other Health CareSeries A$35.1M$5.6Msame sector · same stage
iotaMotion, Inc.Other Health CareSeries A$23.4M$5.0Msame sector · same stage
Igniton, Inc.Other Health CareSeries A$21.6M$4.1Msame sector · same stage
NICO CorpOther Health CareSeries B$58.7M$143.0Mnetwork1 shared operator · same sector
Aria CV, Inc.Other Health CareSeries A$20.3M$4.5Msame sector · same stage
Atraverse Medical, Inc.HealthtechSeries A$33.1M$31.8Mnetwork1 shared operator · same stage
Semantically similar

Matched by meaning, not labels — a local language model reads each company's name, sector and description and ranks the closest in that learned space. This catches look-alikes that cross sector boundaries; the structured list above explains its matches, this one trusts the text. Directional, like every modeled signal here.

CompanySectorStageValue · estMatch
JBK Holdings, LLCOther Health CareSeed$6.3M87%
Jvhd LlcOther Health CarePre-Seed$5.6M86%
JogoHealth, Inc.Other Health CareSeed$6.2M86%
Morris Innovative Inc.Other Health CareSeed$86.7M86%
JDCQ Solutions, LLCOther Health CarePre-Seed$12.3M85%
Gbo Nnhs Asc Jv, LlcOther Health CarePre-Seed$5.4M85%
ConsejoSano, Inc.Other Health CareSeries B$335.7M84%
S&K Holdings, Inc.Other Health CareSeed$47.0M83%
Frequently asked
How much funding has J&J Solutions Inc raised?
J&J Solutions Inc has raised approximately $29.0M in disclosed capital across 6 recorded financing rounds, aggregated from public filings.
What is J&J Solutions Inc's estimated valuation?
Provath's modeled valuation for J&J Solutions Inc is approximately $5.0M (modeled range $320K–$27.4M). This is an algorithmic estimate derived from round sizes and same-niche peers — not a quoted or reported figure.
What funding stage is J&J Solutions Inc at?
J&J Solutions Inc's latest modeled financing stage is Series A. Its most recent recorded round closed around Tue Feb 04.
What does J&J Solutions Inc do and where is it based?
J&J Solutions Inc operates in the Other Health Care sector, based in NEEDHAM.
Explore related

See where J&J Solutions Inc sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.

Is this your company?

If you work at J&J Solutions Inc, claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.

Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.